Liang Zhong-Guo, Zhang Fan, Li Ye, Li Ling, Qu Song, Su Fang, Yu Bin-Bin, Guan Ying, Han Lu, Li Kai-Guo, Zhu Xiao-Dong
Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Cancer Institute of Guangxi Zhuang Autonomous Region, Nanning, China.
Microbiome Research Centre, St George and Sutherland Clinical School, The University of New South Wales Sydney, St George Hospital, Kogarah, NSW, Australia.
Front Oncol. 2021 Nov 11;11:724467. doi: 10.3389/fonc.2021.724467. eCollection 2021.
The present study aimed to evaluate the role of integrating the pretreatment neutrophil-to-lymphocyte ratio (NLR) into the eighth edition of the AJCC staging system for nasopharynx cancer in an endemic region.
Between May 2007 and December 2012, a total of 713 cases with NPC were retrospectively analyzed. The separation ability in terms of overall survival (OS), local failure-free survival (LFFS), distant metastasis-free survival (DMFS), and failure-free survival (FFS) was evaluated. The discriminatory ability was assessed using Harrell's concordance index (c-index). Recursive partitioning analysis (RPA) was conducted and incorporated with pretreatment NLR.
When integrated with NLR, the separate and discriminatory abilities for N classifications were improved in terms of OS and DMFS, but not for T categories. By using Recursive partitioning analysis, five subgroups were generated. Compared with the overall stage, the integration of NLR could not enhance the separate and discriminatory abilities. However, patients in the RPA 4 group gained significant benefits in terms of OS (HR 0.390 (95%CI 0.212-0.716), P = 0.002) and FFS (HR 0.548 (95%CI 0.314-0.958), P = 0.032) from the additional adjuvant chemotherapy after concurrent chemoradiotherapy.
The integration of NLR into the 8 edition of the AJCC staging system could enhance the separation and discriminatory abilities for N classifications, but not for T categories. In addition, patients in the RPA 4 group could benefit from the addition of adjuvant chemotherapy to concurrent chemoradiotherapy.
本研究旨在评估将治疗前中性粒细胞与淋巴细胞比值(NLR)纳入AJCC第八版鼻咽癌分期系统在某流行地区的作用。
回顾性分析2007年5月至2012年12月期间共713例鼻咽癌患者。评估其在总生存期(OS)、无局部复发生存期(LFFS)、无远处转移生存期(DMFS)和无病生存期(FFS)方面的区分能力。使用Harrell一致性指数(c指数)评估鉴别能力。进行递归划分分析(RPA)并结合治疗前NLR。
与NLR整合后,N分类在OS和DMFS方面的区分和鉴别能力有所提高,但T分类未改善。通过递归划分分析,生成了五个亚组。与总体分期相比,NLR的整合未能增强区分和鉴别能力。然而,RPA 4组患者在同步放化疗后接受额外辅助化疗,在OS(HR 0.390(95%CI 0.212 - 0.716),P = 0.002)和FFS(HR 0.548(95%CI 0.314 - 0.958),P = 0.032)方面获得显著益处。
将NLR纳入AJCC第八版分期系统可增强N分类的区分和鉴别能力,但不能增强T分类的能力。此外,RPA 4组患者可从同步放化疗联合辅助化疗中获益。